PharmaTher Launches Personaliz3D Peptides(TM) to Advance Personalized Peptide Care Following Positive FDA Advisory Committee Recommendations
New division will address the limitations of traditional peptide compounding through 3D printing and AIPharmaTher plans to connect patients, physicians and qualified pharmacies through an integrated telemedicine platformPositive PCAC recommendations represent an important potential step toward regulated access to compounded peptides in the United StatesToronto, Ontario--(Newsfile Corp. - July 27, 2026) - PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) ("PharmaTher" or the "Company"), a...
Plan Gratis · Plus 29 CA$ o Pro 99 CA$/mes


